TY  - JOUR
PY  - 2019//
TI  - Update: Demographic, product, and substance-use characteristics of hospitalized patients in a nationwide outbreak of e-cigarette, or vaping, product use-associated lung injuries -United States, December 2019
JO  - MMWR: Morbidity and mortality weekly report
A1  - Lozier, Matthew J.
A1  - Wallace, Bailey
A1  - Anderson, Kayla
A1  - Ellington, Sascha
A1  - Jones, Christopher M.
A1  - Rose, Dale A.
A1  - Baldwin, Grant
A1  - King, Brian A.
A1  - Briss, Peter
A1  - Mikosz, Christina A.
SP  - 1142
EP  - 1148
VL  - 68
IS  - 49
N2  - <p> What is already known about this topic?    Patients with e-cigarette, or vaping, product use–associated lung injury (EVALI) in Illinois and Wisconsin reported using a variety of tetrahydrocannabinol (THC)-containing products in the 3 months preceding illness; a product labeled “Dank Vapes” was most commonly reported.    What is added by this report?    Nationally, Dank Vapes were the most commonly reported THC-containing product by hospitalized EVALI patients, but a wide variety of products were reported, with regional differences. Data suggest the outbreak might have peaked in mid-September.    What are the implications for public health practice?    These data further support the association of EVALI with THC-containing products; it is unlikely that one brand is responsible for the outbreak. CDC recommends that persons not use e-cigarette, or vaping, products that contain THC ...</p>  <p>Language: en</p>
LA  - en
SN  - 0149-2195
UR  - http://dx.doi.org/10.15585/mmwr.mm6849e1
ID  - ref1
ER  -